Highlights

  • Blue Star Helium Limited (ASX:BNL) is producing and selling helium from the Pinon Canyon Plant at its Galactica Project in Colorado.
  • The company extended its current helium offtake agreement through the March 2027 quarter while longer-term arrangements remain under discussion.
  • For the half year ended 30 June 2026, Blue Star reported a loss after tax of A$7.89 million and closed with A$5.0 million in cash and no borrowings.
  • Shareholders are scheduled to consider a proposed security consolidation in October 2026 as operational development continues.

Blue Star Helium Limited (ASX:BNL) was trading at AUD 0.004 on October 7, 2026, up 33.33% during today's trading session. The Australian-headquartered company is focused on helium exploration, development and production in North America. Its main operating activity is the Galactica-Pegasus Project in Colorado, where the Pinon Canyon Plant has moved from commissioning into commercial helium deliveries. Current attention is centred on production consistency, sales arrangements, funding and planned development work.

Company Business

Blue Star's activities cover helium exploration, development and production. The Galactica-Pegasus Project is held through a joint venture, with the project partner holding a 50% working interest. Six wells had been tied into the gathering system by the end of June 2026. Gas is processed at the Pinon Canyon Plant, which removes carbon dioxide before refining the helium-enriched stream for tube-trailer delivery. Blue Star is also assessing carbon dioxide commercialisation as a secondary Revenue stream.

Recent Development

During the first half of 2026, Blue Star completed Stage 1 of the Galactica development programme and continued optimisation of the Pinon Canyon Plant. The first production tube trailer was sold in July, followed by further deliveries. In late August, the company extended its helium purchase and sales agreement to 31 March 2027. The arrangement covers helium produced at Pinon Canyon, with fixed pricing for the extended term. Blue Star continues discussions on longer-term offtake agreements and is working to lift plant output toward design capacity.

Financial Performance and Sector Context

For the six months ended 30 June 2026, Blue Star reported revenue including other income of A$12,198, negative EBITDA of A$4.52 million and a loss after tax of A$7.89 million. No helium sales revenue was recognised because the first completed sale occurred after period end. The company held A$5.0 million in cash and no borrowings at 30 June. During the half, an entitlement offer raised about A$1.06 million before costs and an institutional Placement raised A$10.0 million in gross proceeds. Helium Demand is linked to specialised applications including semiconductor manufacturing, aerospace, healthcare and research, while Supply reliability and logistics remain important industry factors.

Risks to Consider

Operational execution remains a key risk as Blue Star works to improve plant performance and production consistency. The equipment-lease model reduces upfront Capital requirements but creates reliance on equipment suppliers, maintenance providers and coordinated third-party support. Future drilling, well deepening and plant modifications may require additional funding. Production schedules also remain subject to engineering outcomes, approvals, equipment availability and market conditions. Customer arrangements and helium pricing may influence future cash generation.

What to Watch Next

Investors may monitor Pinon Canyon production performance, the cadence of helium deliveries and progress toward longer-term sales agreements. Blue Star is assessing the deepening of existing wells and has indicated plans, subject to permitting, for additional development drilling. Carbon dioxide commercialisation remains dependent on commercial arrangements and plant modifications. Separately, shareholders are scheduled to consider a proposed 50-for-1 consolidation at a general meeting on 20 October 2026, with the timetable providing for post-consolidation trading later that month if approved.

Key Insights

Blue Star has progressed from project development into initial commercial helium sales. The extended offtake agreement provides a sales pathway through the March 2027 quarter while longer-term arrangements are pursued. The company remained loss-making in the first half of 2026 but ended June with cash and no borrowings following capital raisings. Production reliability, funding requirements, development drilling, carbon dioxide commercialisation and the proposed security consolidation remain key monitoring points.